Showing results (21-30 of 177) with videos related to

Sort By:
Pageof 18
Journal of Fungi (Basel, Switzerland)|September 26, 2025
Rare Mould Fungaemia at a Tertiary Academic Hospital in Athens, Greece: A 15-Year Survey and Literature ReviewMaria Siopi, Angeliki Alevra, Dimitrios Mitsopoulos, et al.
Journal of Medical Microbiology|April 2, 2020
Bacterial quantification in tissue homogenates from <i>in vivo</i> pharmacodynamic studies using growth curvesPanagiota-Christina Georgiou, Johan W Mouton, Spyros Pournaras, et al.
International Journal of Antimicrobial Agents|June 4, 2016
Current perspectives on tigecycline resistance in Enterobacteriaceae: susceptibility testing issues and mechanisms of resistanceSpyros Pournaras, Vasiliki Koumaki, Nicholas Spanakis, et al.
Advances in Experimental Medicine and Biology|November 14, 2015
In Vitro Activity of Tigecycline Against Acinetobacter baumannii: Global Epidemiology and Resistance MechanismsSpyros Pournaras, Vasiliki Koumaki, Vasiliki Gennimata, et al.
Diagnostic Microbiology and Infectious Disease|February 23, 2002
Leg ulcer due to Pseudomanas luteola in a patient with sickle cell diseaseAthanassios Tsakris, Helen Hassapopoulou, Lemonia Skoura, et al.
Journal of Water and Health|February 10, 2018
First reported isolation of an emerging opportunistic pathogen (Elizabethkingia anophelis) from hospital water systems in GreeceMaria A Kyritsi, Varvara A Mouchtouri, Spyros Pournaras, et al.
The Journal of Antimicrobial Chemotherapy|March 8, 2007
Characterization of In3Mor, a new integron carrying VIM-1 metallo-beta-lactamase and sat1 gene, from Morganella morganiiAthanassios Tsakris, Alexandros Ikonomidis, Nicholas Spanakis, et al.
Antimicrobial Agents and Chemotherapy|July 3, 2024
Comparative pharmacodynamics and dose optimization of liposomal amphotericin B against <i>Candida</i> species in an <i>in vitro</i> pharmacokinetic/pharmacodynamic modelMaria-Ioanna Beredaki, Maiken C Arendrup, Spyros Pournaras, et al.
Pageof 18